New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 8, 2013
09:37 EDTTHOR, PNG, IT, CFN, NUAN, TCK, IRG, PLD, DE, BG, RVBD, ITW, CMI, TEVA, ANR, OSK, CYS, SKULOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Alpha Natural (ANR) downgraded to Fair Value from Buy at CRT Capital... Riverbed (RVBD) downgraded to Market Perform from Outperform at FBR Capital... Skullcandy (SKUL) downgraded to Neutral from Buy at Roth Capital... Teva (TEVA) downgraded to Hold from Buy at Canaccord... Bunge (BG) downgraded to Hold from Strong Buy at Feltl... CYS Investments (CYS) downgraded to Neutral from Buy at Compass Point... Deere (DE) downgraded to Buy from Strong Buy at ISI Group... Cummins (CMI) downgraded to Buy from Strong Buy at ISI Group.. Oshkosh (OSK) downgraded to Buy from Strong Buy at ISI Group... Illinois Tool Works (ITW) downgraded to Buy from Strong Buy at ISI Group... Gartner (IT) downgraded to Neutral from Overweight at Piper Jaffray... ProLogis (PLD) downgraded to Hold from Buy at Stifel Nicolaus... Nuance (NUAN) downgraded to Hold from Buy at Stifel Nicolaus... CYS Investments (CYS) downgraded to Hold from Buy at Stifel Nicolaus... PAA Natural Gas Storage (PNG) downgraded to Market Perform from Outperform at Raymond James... Ignite Restaurant (IRG) downgraded to Outperform from Strong Buy at Raymond James... CareFusion (CFN) downgraded to Outperform from Buy at CLSA... Riverbed (RVBD) downgraded to Neutral from Buy at Lazard Capital... Thoratec (THOR) downgraded to Market Perform from Outperform at Northland Securities... Teck Resources (TCK) downgraded to Neutral from Overweight at JPMorgan.
News For ANR;RVBD;SKUL;TEVA;BG;CYS;CMI;DE;OSK;ITW;IT;PLD;NUAN;PNG;IRG;CFN;THOR;TCK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
August 4, 2015
12:11 EDTDEDeere recalls lawn tractors due to crash hazard
Subscribe for More Information
10:01 EDTCMIOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:22 EDTCMICummins downgraded to Hold from Buy at Evercore ISI
06:04 EDTTEVAStocks with implied volatility below IV index mean; TEVA GOOG
Subscribe for More Information
August 3, 2015
16:42 EDTTEVASagent Pharmaceuticals appoints Oberman as CEO
Subscribe for More Information
08:56 EDTOSKPierce announces order for 48 custom apparatus from Kansas City Fire Department
Subscribe for More Information
08:09 EDTTEVATeva buys 51% equity share in Immuneering
Subscribe for More Information
07:28 EDTTEVATeva reinstated with an Overweight from Neutral at JPMorgan
Subscribe for More Information
06:01 EDTTEVAStocks with implied volatility below IV index mean; TEVA GOOG
Subscribe for More Information
July 31, 2015
16:22 EDTTEVAStocks end week higher in U.S. despite selloff in China
Subscribe for More Information
13:31 EDTTEVATeva secures $33.75B financing commitment
Subscribe for More Information
08:59 EDTOSKOshkosh outlook still positive, says Stifel
Subscribe for More Information
07:51 EDTTEVATeva outlook positive, says Bernstein
After Teva reported better than expected Q2 results but the stock fell, Bernstein blames the stock's decline on profit taking by value funds, a decision by potential buyers of the stock to wait for the Copaxone institution decision on August 26 before purchasing the shares, and temporary shorting by hedge funds ahead of August 26. The firm says that the company's pipeline should excite investors, while the Actavis business which Teva recently bought should keep its EPS above $5 even in a sudden Copaxone loss scenario, according to the firm. Bernstein keeps an $80 price target and Outperform rating on Teva.
05:58 EDTTEVAStocks with implied volatility below IV index mean; TEVA GOOG
Subscribe for More Information
July 30, 2015
09:25 EDTOSKOn The Fly: Pre-market Movers
Subscribe for More Information
09:22 EDTOSKOshkosh downgraded to Hold from Buy at Drexel Hamilton
Subscribe for More Information
09:04 EDTTEVATeva says R&D update meeting will be held before year-end
Subscribe for More Information
08:25 EDTTEVATeva CEO says 'too early' to provide specifics on other potential deals
08:11 EDTTEVATeva CEO says Allergan deal financing commitment expected in next few days
Subscribe for More Information
07:25 EDTITGartner reports Q2 Research revenue up 8% to $385.7M
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use